Related Experiment Video
Updated: Feb 3, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
Does intratympanic xylitol administration have ototoxic effects in a mouse ear model?
Eda Tuna Yalcinozan1, Ebru Kösemihal2, Mehmet Ates Aksit2
1Department of Otorhinolaryngology, Near East University, Faculty of Medicine, Nicosia, 99138, Cyprus.
Intratympanic xylitol injections in a mouse model showed no ototoxic effects on the inner ear. Further clinical studies are needed to confirm these findings regarding xylitol
Area of Science:
- Ototoxicology
- Auditory Neuroscience
- Pharmacology
Background:
- Xylitol is a sugar alcohol with various applications.
- Intratympanic injections are used for localized drug delivery to the inner ear.
- Research is needed to assess the safety of xylitol via this administration route.
Purpose of the Study:
- To investigate the potential ototoxicity of xylitol administered intratympanically in a mouse model.
- To evaluate the safety of different concentrations of xylitol in the middle ear.
Main Methods:
- 24 female Balb/c mice were divided into four groups.
- Groups received intratympanic injections of 0.9% NaCl or varying concentrations of xylitol (155, 310, 620 mg/ml).
- Auditory brainstem response tests and microscopic ear examinations were performed before and after injection.
Main Results:
- Statistically significant alterations in auditory threshold values were observed at high frequencies (8000-24000 Hz).
- These changes were independent of xylitol dosage.
- No clear dose-dependent ototoxic effects were identified.
Conclusions:
- Intratympanic xylitol injection did not demonstrate ototoxic effects in the mouse inner ear.
- Further clinical investigations are warranted to fully ascertain the effects of xylitol.
Related Concept Videos
One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model
Zero-order absorption maintains a steady rate irrespective of the amount of drug left to be absorbed, making it a constant process. In the...
Two-Compartment Open Model: Extravascular Administration
The absorption exponent (ka) indicates the speed at which the drug...
One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model
Anatomy of the Ear
Two-Compartment Open Model: IV Bolus Administration
The disparity between drug input and the sum of drug transfer rates between...
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...

